[A New Era of Cancer Prevention from Dentistry] Saliva Cancer Risk Testing Bridges Medical Care: Promoting Early Detection via Oral Care to Enhance Health Span

Salivatech (Headquarters: Tsuruoka, Yamagata; CEO: Makoto Sunamura), provider of the saliva-based cancer risk test "SalivaChecker®," announced that Masahiro Sugimoto, Director of Salivatech (and Professor at Keio University Graduate School of Media and Governance), and Remi Onuma, Medical Institutional Sales, presented at a luncheon seminar during the 23rd Annual Meeting of the Japanese Society of Oral Care.

The seminar highlighted the utility of saliva testing in the dental and oral care field, systemic cancer risk assessment through oral care, and bridging patients to appropriate medical treatment to increase health span, drawing significant interest from medical professionals.

Seminar Overview Seminar Title: Luncheon Seminar "Unlocking Systemic Signals through Oral Care" Speaker 1: "Perspectives Connecting Oral Care and Systemic Management" - Masahiro Sugimoto Speaker 2: "A New Option for Early Cancer Detection: Saliva Cancer Risk Test 'SalivaChecker'" - Remi Onuma

From Oral Care to Systemic Health: Salivatech's Story of Enhancing Health Span Recent studies show that poor oral care is not only a cause of tooth decay and periodontal disease but can also trigger serious systemic diseases. Salivatech believes that by incorporating saliva testing into routine oral care at dental clinics, patients can be connected to appropriate medical treatment, contributing to increased health span.

Covering 6 Types of Cancer with One Drop of Saliva SalivaChecker® can evaluate the risk of 6 types of cancer simultaneously: oral cancer, pancreatic cancer, lung cancer, stomach cancer, colorectal cancer, and breast cancer (women only).

Bridging from 'Notice' to 'Appropriate Medical Care' By testing at dental clinics, which are visited regularly, potential cancer risks can be visualized even in the asymptomatic stage. The company constructs a mechanism to smoothly bridge patients with high risk scores to appropriate medical institutions.

Seminar Survey: Over 85% Satisfied - Participant satisfaction was 85.2%. - Diverse participants: Dentists (18.5%), Dental Hygienists (30.9%), Nurses (30.9%). - Facility types: Hospitals (61.3%), Dental Clinics (10.0%). - Practicality: 72.7% found the test 'useful' for clinical work.